Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity.
暂无分享,去创建一个
C. Walker | H. Yoon | T. Monks | J. Everitt | S. Lau
[1] H. Yoon,et al. Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis‐2 tumor suppressor gene , 2001, Molecular carcinogenesis.
[2] T. Monks,et al. Stress- and growth-related gene expression are independent of chemical-induced prostaglandin E(2) synthesis in renal epithelial cells. , 2000, Chemical research in toxicology.
[3] H. Onda,et al. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. , 1999, The Journal of clinical investigation.
[4] T. Monks,et al. Quinol-glutathione conjugate-induced mutation spectra in the supF gene replicated in human AD293 cells and bacterial MBL50 cells. , 1999, Cancer research.
[5] R. Safirstein,et al. MAPK activation determines renal epithelial cell survival during oxidative injury. , 1999, American journal of physiology. Renal physiology.
[6] Alan R. Saltiel,et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo , 1999, Nature Medicine.
[7] A. DeCaprio. The toxicology of hydroquinone--relevance to occupational and environmental exposure. , 1999, Critical reviews in toxicology.
[8] T. Noda,et al. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. , 1999, Cancer research.
[9] J. Usuda,et al. Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells. , 1999, International journal of oncology.
[10] G. Rubin,et al. gigas , a Drosophila Homolog of Tuberous Sclerosis Gene Product-2, Regulates the Cell Cycle , 1999, Cell.
[11] Takashi Tsuruo,et al. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors , 1999, Oncogene.
[12] R. Yeung,et al. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Kleiner,et al. Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant to quinol-thioether-mediated nephrotoxicity. , 1998, Chemical Research in Toxicology.
[14] H. Onda,et al. Tuberous Sclerosis Gene 2 Product Modulates Transcription Mediated by Steroid Hormone Receptor Family Members* , 1998, The Journal of Biological Chemistry.
[15] E. Mccleskey,et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor , 1998, Nature.
[16] Weiya Ma,et al. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] C. Walker. Molecular Genetics of Renal Carcinogenesis , 1998, Toxicologic pathology.
[18] T. Monks,et al. Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone. , 1997, Carcinogenesis.
[19] J. Declue,et al. Role of the Tuberous Sclerosis Gene-2 Product in Cell Cycle Control , 1997, The Journal of Biological Chemistry.
[20] N. Minato,et al. Human SPA-1 Gene Product Selectively Expressed in Lymphoid Tissues Is a Specific GTPase-activating Protein for Rap1 and Rap2 , 1997, The Journal of Biological Chemistry.
[21] H. Tsuda,et al. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. , 1997, The Journal of urology.
[22] M. Cobb,et al. Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.
[23] D. Wolf,et al. Methyltert-Butyl Ether Causes α2u-Globulin Nephropathy and Enhanced Renal Cell Proliferation in Male Fischer-344 Rats , 1997 .
[24] E. Golemis,et al. The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.
[25] J. Bonifacino,et al. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. , 1996, Oncogene.
[26] J. Pouysségur,et al. Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.
[27] J. Declue,et al. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] T. Kobayashi,et al. Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells. , 1996, Biochemical and biophysical research communications.
[29] S. Kuroda,et al. Activation of Brain B-Raf Protein Kinase by Rap1B Small GTP-binding Protein (*) , 1996, The Journal of Biological Chemistry.
[30] A. Scabar,et al. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas , 1996, Genes, chromosomes & cancer.
[31] T. Goldsworthy,et al. Hereditary renal cell carcinoma in the Eker rat: a unique animal model for the study of cancer susceptibility. , 1995, Toxicology Letters.
[32] M. Kawaichi,et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.
[33] G. Xiao,et al. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat , 1995, Molecular carcinogenesis.
[34] Peter J. Cullen,et al. Identification of a specific lns(l,3,4,5)P4-binding protein as a member of the GAP1 family , 1995, Nature.
[35] T. Kobayashi,et al. cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. , 1995, Nucleic acids research.
[36] J. Declue,et al. Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.
[37] K. Okazaki,et al. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. , 1995, Oncogene.
[38] Y. Kubo,et al. Early detection of Knudson's two-hits in preneoplastic renal cells of the Eker rat model by the laser microdissection procedure. , 1995, Cancer research.
[39] A. Knudson,et al. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] C. Walker,et al. Increased susceptibility to in vitro transformation of cells carrying the Eker tumor susceptibility mutation. , 1994, Carcinogenesis.
[41] Y. Kubo,et al. Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in the Eker rat. , 1994, Cancer research.
[42] A. Brunet,et al. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.
[43] A. Green,et al. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients , 1994, Nature Genetics.
[44] S. Thomas,et al. Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.
[45] A. Knudson,et al. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Huff,et al. Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. , 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[47] T. Sasaki,et al. Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes , 1992, Molecular and cellular biology.
[48] T. Goldsworthy,et al. Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. , 1992, Science.
[49] M. Hirose,et al. Induction of Renal Cell Tumors in Rats and Mice, and Enhancement of Hepatocellular Tumor Development in Mice after Long‐term Hydroquinone Treatment , 1991, Japanese journal of cancer research : Gann.
[50] F. McCormick,et al. Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21 rap1 , 1991, Cell.
[51] T. Monks,et al. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. , 1988, Molecular pharmacology.
[52] S. Mizusaki,et al. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97. , 1985, Mutation research.
[53] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[54] R. Velsen,et al. Centrosema Mosaic: a Plant Virus Disease transmitted by both Aphids and Plant Bugs , 1961, Nature.
[55] J. Mossige,et al. A Dominant Gene for Renal Adenomas in the Rat , 1961, Nature.
[56] C. Walker,et al. Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone. , 2001, Chemical research in toxicology.
[57] J. de Gunzburg,et al. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. , 1997, The American journal of pathology.
[58] D. Wolf,et al. Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats. , 1997, Toxicology and applied pharmacology.
[59] Deisinger Pj,et al. HUMAN EXPOSURE TO NATURALLY OCCURRING HYDROQUINONE , 1996 .
[60] Y. Kubo,et al. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer , 1995, Nature Genetics.
[61] I. Florin,et al. Screening of tobacco smoke constituents for mutagenicity using the Ames' test. , 1980, Toxicology.